Clinical Trial Update: Effects of Roflumilast on Insulin and Blood Sugar Levels in Prediabetic Overweight and Obese Individuals [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating the effects of roflumilast on insulin and blood sugar levels in overweight or obese individuals with prediabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Prediabetes

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Obesity | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-09-04